Cargando…

Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by (1)H HR-MAS NMR Metabolomics

Multiple myeloma (MM) is a malignancy of plasma cells characterized by multifocal osteolytic bone lesions. Macroscopic and genetic heterogeneity has been documented within MM lesions. Understanding the bases of such heterogeneity may unveil relevant features of MM pathobiology. To this aim, we deplo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tavel, Laurette, Fontana, Francesca, Garcia Manteiga, Josè Manuel, Mari, Silvia, Mariani, Elisabetta, Caneva, Enrico, Sitia, Roberto, Camnasio, Francesco, Marcatti, Magda, Cenci, Simone, Musco, Giovanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133815/
https://www.ncbi.nlm.nih.gov/pubmed/27809247
http://dx.doi.org/10.3390/ijms17111814
_version_ 1782471344660676608
author Tavel, Laurette
Fontana, Francesca
Garcia Manteiga, Josè Manuel
Mari, Silvia
Mariani, Elisabetta
Caneva, Enrico
Sitia, Roberto
Camnasio, Francesco
Marcatti, Magda
Cenci, Simone
Musco, Giovanna
author_facet Tavel, Laurette
Fontana, Francesca
Garcia Manteiga, Josè Manuel
Mari, Silvia
Mariani, Elisabetta
Caneva, Enrico
Sitia, Roberto
Camnasio, Francesco
Marcatti, Magda
Cenci, Simone
Musco, Giovanna
author_sort Tavel, Laurette
collection PubMed
description Multiple myeloma (MM) is a malignancy of plasma cells characterized by multifocal osteolytic bone lesions. Macroscopic and genetic heterogeneity has been documented within MM lesions. Understanding the bases of such heterogeneity may unveil relevant features of MM pathobiology. To this aim, we deployed unbiased (1)H high-resolution magic-angle spinning (HR-MAS) nuclear magnetic resonance (NMR) metabolomics to analyze multiple biopsy specimens of osteolytic lesions from one case of pathological fracture caused by MM. Multivariate analyses on normalized metabolite peak integrals allowed clusterization of samples in accordance with a posteriori histological findings. We investigated the relationship between morphological and NMR features by merging morphological data and metabolite profiling into a single correlation matrix. Data-merging addressed tissue heterogeneity, and greatly facilitated the mapping of lesions and nearby healthy tissues. Our proof-of-principle study reveals integrated metabolomics and histomorphology as a promising approach for the targeted study of osteolytic lesions.
format Online
Article
Text
id pubmed-5133815
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-51338152016-12-12 Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by (1)H HR-MAS NMR Metabolomics Tavel, Laurette Fontana, Francesca Garcia Manteiga, Josè Manuel Mari, Silvia Mariani, Elisabetta Caneva, Enrico Sitia, Roberto Camnasio, Francesco Marcatti, Magda Cenci, Simone Musco, Giovanna Int J Mol Sci Article Multiple myeloma (MM) is a malignancy of plasma cells characterized by multifocal osteolytic bone lesions. Macroscopic and genetic heterogeneity has been documented within MM lesions. Understanding the bases of such heterogeneity may unveil relevant features of MM pathobiology. To this aim, we deployed unbiased (1)H high-resolution magic-angle spinning (HR-MAS) nuclear magnetic resonance (NMR) metabolomics to analyze multiple biopsy specimens of osteolytic lesions from one case of pathological fracture caused by MM. Multivariate analyses on normalized metabolite peak integrals allowed clusterization of samples in accordance with a posteriori histological findings. We investigated the relationship between morphological and NMR features by merging morphological data and metabolite profiling into a single correlation matrix. Data-merging addressed tissue heterogeneity, and greatly facilitated the mapping of lesions and nearby healthy tissues. Our proof-of-principle study reveals integrated metabolomics and histomorphology as a promising approach for the targeted study of osteolytic lesions. MDPI 2016-10-31 /pmc/articles/PMC5133815/ /pubmed/27809247 http://dx.doi.org/10.3390/ijms17111814 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tavel, Laurette
Fontana, Francesca
Garcia Manteiga, Josè Manuel
Mari, Silvia
Mariani, Elisabetta
Caneva, Enrico
Sitia, Roberto
Camnasio, Francesco
Marcatti, Magda
Cenci, Simone
Musco, Giovanna
Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by (1)H HR-MAS NMR Metabolomics
title Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by (1)H HR-MAS NMR Metabolomics
title_full Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by (1)H HR-MAS NMR Metabolomics
title_fullStr Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by (1)H HR-MAS NMR Metabolomics
title_full_unstemmed Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by (1)H HR-MAS NMR Metabolomics
title_short Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by (1)H HR-MAS NMR Metabolomics
title_sort assessing heterogeneity of osteolytic lesions in multiple myeloma by (1)h hr-mas nmr metabolomics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133815/
https://www.ncbi.nlm.nih.gov/pubmed/27809247
http://dx.doi.org/10.3390/ijms17111814
work_keys_str_mv AT tavellaurette assessingheterogeneityofosteolyticlesionsinmultiplemyelomaby1hhrmasnmrmetabolomics
AT fontanafrancesca assessingheterogeneityofosteolyticlesionsinmultiplemyelomaby1hhrmasnmrmetabolomics
AT garciamanteigajosemanuel assessingheterogeneityofosteolyticlesionsinmultiplemyelomaby1hhrmasnmrmetabolomics
AT marisilvia assessingheterogeneityofosteolyticlesionsinmultiplemyelomaby1hhrmasnmrmetabolomics
AT marianielisabetta assessingheterogeneityofosteolyticlesionsinmultiplemyelomaby1hhrmasnmrmetabolomics
AT canevaenrico assessingheterogeneityofosteolyticlesionsinmultiplemyelomaby1hhrmasnmrmetabolomics
AT sitiaroberto assessingheterogeneityofosteolyticlesionsinmultiplemyelomaby1hhrmasnmrmetabolomics
AT camnasiofrancesco assessingheterogeneityofosteolyticlesionsinmultiplemyelomaby1hhrmasnmrmetabolomics
AT marcattimagda assessingheterogeneityofosteolyticlesionsinmultiplemyelomaby1hhrmasnmrmetabolomics
AT cencisimone assessingheterogeneityofosteolyticlesionsinmultiplemyelomaby1hhrmasnmrmetabolomics
AT muscogiovanna assessingheterogeneityofosteolyticlesionsinmultiplemyelomaby1hhrmasnmrmetabolomics